Article

Cane Use Doesn’t Foster the Growth of Bone Marrow Lesions

OARSI 2019:  Using a cane may not foster the growth of medial tibiofemoral bone marrow lesions (BML) in knee osteoarthritis.

(©Tevalux11, AdobeStock)

(©Tevalux11, AdobeStock)

Australian researchers reporting at the Osteoarthritis Research Society International (OARSI) World Congress on Osteoarthritis held this weekend in Toronto, say that the use of cane by osteoarthritis patients does not worsen or improve medial tibiofemoral bone marrow lesions (BML) in knee osteoarthritis.

“We found no evidence of an effect of cane use for approximately 2-3 hours per day over 3 months on medial tibiofemoral BML volume changes, compared to not using any gait aids,” A. Van Ginckel, et al. wrote in the April issue of the journal Osteoarthritis and Cartilage.

The findings were presented at OARSI on Friday. Patients with knee osteoarthritis are believed to be at high risk for developing bone marrow lesions, cartilage loss and structural deterioration due to joint loading. But in this study of 78 patients, no such evidence was found. 

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.